Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Cosmai

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
British Journal of Clinical Pharmacology|January 19, 2010
Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapyLaurent R Chiarelli, Mariadelfina Molinaro, Carmelo Libetta, et al.
Journal of Nephrology|October 27, 2015
Glomerular diseases and cancer: evaluation of underlying malignancyAntonello Pani, Camillo Porta, Laura Cosmai, et al.
Cancer Treatment Reviews|March 16, 2024
How to deal with renal toxicities from immune-based combination treatments in metastatic renal cell carcinoma. A nephrological consultation for OncologistsMarcello Tucci, Laura Cosmai, Marta Pirovano, et al.
Targeted Oncology|October 17, 2018
Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted TherapyFrancesco Massari, Vincenzo Di Nunno, Lidia Gatto, et al.
Clinical Genitourinary Cancer|May 14, 2026
Comparative and Critical Analysis of Immune-based Combinations for First-line Treatment of Metastatic Renal Cell CarcinomaTomer Meirson, Luciano Mutti, Daniel A Goldstein, et al.
Journal of Nephrology|November 22, 2015
Transplantation of kidneys with tumorsGiovanni M Frascà, Antonia D'Errico, Deborah Malvi, et al.
Lancet (London, England)|July 22, 2022
The multispeciality approach to the management of localised kidney cancerGrant D Stewart, Tobias Klatte, Laura Cosmai, et al.
Critical Reviews in Oncology/Hematology|June 9, 2019
Management of targeted therapies in cancer patients with chronic kidney disease, or on haemodialysis: An Associazione Italiana di Oncologia Medica (AIOM)/Societa' Italiana di Nefrologia (SIN) multidisciplinary consensus position paperNicola Silvestris, Antonella Argentiero, Laura Cosmai, et al.
Journal of Nephrology|July 24, 2015
Renal cancer in kidney transplanted patientsGiovanni M Frascà, Silvio Sandrini, Laura Cosmai, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 15, 2007
Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokinesCarmelo Libetta, Vincenzo Sepe, Manuela Zucchi, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
British Journal of Clinical Pharmacology|January 19, 2010
Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapyLaurent R Chiarelli, Mariadelfina Molinaro, Carmelo Libetta, et al.
Journal of Nephrology|October 27, 2015
Glomerular diseases and cancer: evaluation of underlying malignancyAntonello Pani, Camillo Porta, Laura Cosmai, et al.
Cancer Treatment Reviews|March 16, 2024
How to deal with renal toxicities from immune-based combination treatments in metastatic renal cell carcinoma. A nephrological consultation for OncologistsMarcello Tucci, Laura Cosmai, Marta Pirovano, et al.
Targeted Oncology|October 17, 2018
Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted TherapyFrancesco Massari, Vincenzo Di Nunno, Lidia Gatto, et al.
Clinical Genitourinary Cancer|May 14, 2026
Comparative and Critical Analysis of Immune-based Combinations for First-line Treatment of Metastatic Renal Cell CarcinomaTomer Meirson, Luciano Mutti, Daniel A Goldstein, et al.
Journal of Nephrology|November 22, 2015
Transplantation of kidneys with tumorsGiovanni M Frascà, Antonia D'Errico, Deborah Malvi, et al.
Lancet (London, England)|July 22, 2022
The multispeciality approach to the management of localised kidney cancerGrant D Stewart, Tobias Klatte, Laura Cosmai, et al.
Critical Reviews in Oncology/Hematology|June 9, 2019
Management of targeted therapies in cancer patients with chronic kidney disease, or on haemodialysis: An Associazione Italiana di Oncologia Medica (AIOM)/Societa' Italiana di Nefrologia (SIN) multidisciplinary consensus position paperNicola Silvestris, Antonella Argentiero, Laura Cosmai, et al.
Journal of Nephrology|July 24, 2015
Renal cancer in kidney transplanted patientsGiovanni M Frascà, Silvio Sandrini, Laura Cosmai, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 15, 2007
Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokinesCarmelo Libetta, Vincenzo Sepe, Manuela Zucchi, et al.
Pageof 7